Screener
Ginkgo Bioworks DNA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $9,575 | $10,566 |
| Deferred revenue (includes $98 and $98 from related parties) | 13,214 | 18,946 |
| Accrued expenses and other current liabilities (includes $2,513 and zero from related parties) | 49,951 | 66,458 |
| Total current liabilities | 72,740 | 95,970 |
| Non-current liabilities: | ||
| Deferred revenue, net of current portion (includes $64,810 and $64,787 from related parties) | 76,537 | 75,182 |
| Operating lease liabilities, non-current | 404,113 | 417,078 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's accrued expenses?
- Ginkgo Bioworks (DNA) reported accrued expenses of $49.95M in Q2 2026.
- How has Ginkgo Bioworks's accrued expenses changed year-over-year?
- Ginkgo Bioworks's accrued expenses decreased by 12.7% year-over-year, from $57.23M to $49.95M.
- What is the long-term trend for Ginkgo Bioworks's accrued expenses?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's accrued expenses has grown at a 16.9% compound annual growth rate (CAGR), from $30.51M to $66.46M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Ginkgo Bioworks's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude